These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 39155364)
1. Association between dichotomized VASARI feature and overall survival in glioblastoma patients: a single-institution propensity score matching analysis. Han Y; Wang YY; Yang Y; Qiao SQ; Liu ZC; Cui GB; Yan LF Cancer Imaging; 2024 Aug; 24(1):109. PubMed ID: 39155364 [TBL] [Abstract][Full Text] [Related]
2. Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients. Peeken JC; Hesse J; Haller B; Kessel KA; Nüsslin F; Combs SE Strahlenther Onkol; 2018 Jun; 194(6):580-590. PubMed ID: 29442128 [TBL] [Abstract][Full Text] [Related]
3. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma. Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505 [TBL] [Abstract][Full Text] [Related]
4. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients. Chaddad A; Sabri S; Niazi T; Abdulkarim B Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951 [TBL] [Abstract][Full Text] [Related]
5. Nomogram incorporating preoperative MRI-VASARI features for differentiating intracranial extraventricular ependymoma from glioblastoma. Yao Y; Fu Y; Zhou G; Wang X; Li L; Mao Y; Wang J; Tan Z; Jiang M; Yi X; Chen BT Quant Imaging Med Surg; 2024 Mar; 14(3):2255-2266. PubMed ID: 38545063 [TBL] [Abstract][Full Text] [Related]
6. Vasari-Based Features Nomogram to Predict the Tumor-Infiltrating CD8+ T Cell Levels in Glioblastoma. Xue C; Zhou Q; Zhang B; Ke X; Zhang P; Liu X; Li S; Deng J; Zhou J Acad Radiol; 2024 May; 31(5):2050-2060. PubMed ID: 37985291 [TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme. Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472 [TBL] [Abstract][Full Text] [Related]
8. Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas. Setyawan NH; Choridah L; Nugroho HA; Malueka RG; Dwianingsih EK Cancer Imaging; 2024 Jan; 24(1):3. PubMed ID: 38167551 [TBL] [Abstract][Full Text] [Related]
9. Combining multimodal imaging and treatment features improves machine learning-based prognostic assessment in patients with glioblastoma multiforme. Peeken JC; Goldberg T; Pyka T; Bernhofer M; Wiestler B; Kessel KA; Tafti PD; Nüsslin F; Braun AE; Zimmer C; Rost B; Combs SE Cancer Med; 2019 Jan; 8(1):128-136. PubMed ID: 30561851 [TBL] [Abstract][Full Text] [Related]
10. Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach. Cao M; Suo S; Zhang X; Wang X; Xu J; Yang W; Zhou Y Biomed Res Int; 2021; 2021():1235314. PubMed ID: 33553421 [TBL] [Abstract][Full Text] [Related]
11. Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance. Azizova A; Prysiazhniuk Y; Wamelink IJHG; Petr J; Barkhof F; Keil VC AJNR Am J Neuroradiol; 2024 Aug; 45(8):1053-1062. PubMed ID: 38937115 [TBL] [Abstract][Full Text] [Related]
12. Assessment of Ki-67 expression levels in IDH-wildtype glioblastoma using logistic regression modelling of VASARI features. Bai L; Jiang J; Zhou J Neurosurg Rev; 2023 Dec; 47(1):20. PubMed ID: 38135816 [TBL] [Abstract][Full Text] [Related]
13. Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma. Verduin M; Primakov S; Compter I; Woodruff HC; van Kuijk SMJ; Ramaekers BLT; te Dorsthorst M; Revenich EGM; ter Laan M; Pegge SAH; Meijer FJA; Beckervordersandforth J; Speel EJ; Kusters B; de Leng WWJ; Anten MM; Broen MPG; Ackermans L; Schijns OEMG; Teernstra O; Hovinga K; Vooijs MA; Tjan-Heijnen VCG; Eekers DBP; Postma AA; Lambin P; Hoeben A Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578746 [TBL] [Abstract][Full Text] [Related]
14. Identifying overall survival in 98 glioblastomas using VASARI features at 3T. Sacli-Bilmez B; Firat Z; Topcuoglu OM; Yaltirik K; Ture U; Ozturk-Isik E Clin Imaging; 2023 Jan; 93():86-92. PubMed ID: 36417792 [TBL] [Abstract][Full Text] [Related]
16. Regression based overall survival prediction of glioblastoma multiforme patients using a single discovery cohort of multi-institutional multi-channel MR images. Sanghani P; Ang BT; King NKK; Ren H Med Biol Eng Comput; 2019 Aug; 57(8):1683-1691. PubMed ID: 31104273 [TBL] [Abstract][Full Text] [Related]
17. Preoperative prediction of MGMT promoter methylation in glioblastoma based on multiregional and multi-sequence MRI radiomics analysis. Li L; Xiao F; Wang S; Kuang S; Li Z; Zhong Y; Xu D; Cai Y; Li S; Chen J; Liu Y; Li J; Li H; Xu H Sci Rep; 2024 Jul; 14(1):16031. PubMed ID: 38992201 [TBL] [Abstract][Full Text] [Related]
18. The added prognostic value of radiological phenotype combined with clinical features and molecular subtype in anaplastic gliomas. Lee M; Han K; Ahn SS; Bae S; Choi YS; Hong JB; Chang JH; Kim SH; Lee SK J Neurooncol; 2019 Mar; 142(1):129-138. PubMed ID: 30604396 [TBL] [Abstract][Full Text] [Related]
19. Potential Utility of Visually AcceSAble Rembrandt Images Assessment in Brain Astrocytoma Grading. Yu J; Wang M; Song J; Huang D; Hong X J Comput Assist Tomogr; 2016; 40(2):301-6. PubMed ID: 26978002 [TBL] [Abstract][Full Text] [Related]